Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 7, 2012, Pages 1145-1154

  Borrull, Aurelie ^a,b   Ghislin, Stephanie ^a   Deshayes, Frederique ^a   Lauriol, Jessica ^a,c   Alcaide Loridan, Catherine ^a   Middendorp, Sandrine ^a  

^a INSTITUT JACQUES MONOD   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

A375 melanoma cell line; Amoeboid movement; Mesenchymal movement; Nanog; Oct4

Indexed keywords

EPHRIN RECEPTOR A2; FOCAL ADHESION KINASE; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN CDC42; RAC PROTEIN; TALIN; TRANSCRIPTION FACTOR NANOG;

ARHGAP22 GENE; ARTICLE; CDC42 GENE; CELL MOTILITY; CONTROLLED STUDY; DOCK10 GENE; EPHA2 GENE; FAK GENE; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INT BETA1 GENE; MELANOMA CELL; MESENCHYME CELL; MT1 MMP GENE; NANOG GENE; OCT4 GENE; ONCOGENE SRC; PAXILLIN GENE; PRIORITY JOURNAL; RAC GENE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMURF1 GENE; STABLE TRANSFECTION; TALIN2 GENE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; WOUND HEALING;

CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MELANOMA; OCTAMER TRANSCRIPTION FACTOR-3;

EID: 84864338902     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1186-2     Document Type: Article

References (38)

1. Belgiovine C, Frapolli R, Bonezzi K, Chiodi I, Favero F, Mello- Grand M, Dei Tos AP, Giulotto E, Taraboletti G, D'Incalci M, Mondello C (2010) Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells. PLoS One 5(11):e14154. doi:10.1371/journal.pone.0014154
2. Bhatia S, Tykodi SS, Thompson JA (2009) Treatment of metastatic melanoma: an overview. Oncology (Williston Park) 23(6): 488-496
3. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, Wu CL (2008) Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 68(15):6281-6291. doi:10.1158/ 0008-5472.CAN-08-0094
4. Cheli Y, Giuliano S, Botton T, Rocchi S, Hofman V, Hofman P, Bahadoran P, Bertolotto C, Ballotti R (2011) Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene 30(20):2307-2318. doi:10.1038/onc.2010.598
5. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, Wu CW (2010) Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res 70(24):10433-10444. doi:10.1158/0008-5472.CAN-10-2638
6. Cicchini C, Laudadio I, Citarella F, Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L, Tripodi M (2008) TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res 314(1):143-152. doi:10.1016/j.yexcr. 2007.09.005 (Pubitemid 350180782)
7. Clark EA, Golub TR, Lander ES, Hynes RO (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406(6795):532-535. doi:10.1038/35020106 (Pubitemid 30625739)
8. Du Z, Jia D, Liu S, Wang F, Li G, Zhang Y, Cao X, Ling EA, Hao A (2009) Oct4 is expressed in human gliomas and promotes colony formation in glioma cells. Glia 57(7):724-733. doi:10.1002/ glia.20800
9. Fluge O, Bruland O, Akslen LA, Lillehaug JR, Varhaug JE (2006) Gene expression in poorly differentiated papillary thyroid carcinomas. Thyroid 16(2):161-175
10. Gadea G, Sanz-Moreno V, Self A, Godi A, Marshall CJ (2008) DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells. Curr Biol 18(19):1456-1465. doi: 10.1016/j.cub.2008.08.053
11. Ghislin S, Obino D, Middendorp S, Boggetto N, Alcaide-Loridan C, Deshayes F (2011) Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro. Pigment Cell Melanoma Res 24(3):504-511. doi:10.1111/j. 1755-148X.2011.00856.x
12. Ghislin S, Deshayes F, Lauriol J, Middendorp S, Martins I, Al-Daccak R, Alcaide-Loridan C (in press) Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth. Melanoma Res
13. Ghosh S, Spagnoli GC, Martin I, Ploegert S, Demougin P, Heberer M, Reschner A (2005) Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study. J Cell Physiol 204(2):522-531. doi: 10.1002/jcp.20320 (Pubitemid 40934647)
14. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL, Federman S, Miller JR 3rd, Allen RE, Singer MI, Leong SP, Ljung BM, Sagebiel RW, Kashani-Sabet M (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102(17):6092-6097. doi:10.1073/pnas. 0501564102 (Pubitemid 40594260)
15. Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R, Weber BL, Nathanson KL, Phillips DJ, Herlyn M, Schadendorf D, Dummer R (2006) Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 19(4):290-302. doi:10.1111/j.1600-0749.2006.00322.x (Pubitemid 44015592)
16. Hoek KS, Eichhoff OM, Schlegel NC, Dobbeling U, Kobert N, Schaerer L, Hemmi S, Dummer R (2008) In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 68(3):650-656. doi:10.1158/0008-5472.CAN-07-2491 (Pubitemid 351206739)
17. Jeffs AR, Glover AC, Slobbe LJ, Wang L, He S, Hazlett JA, Awasthi A, Woolley AG, Marshall ES, Joseph WR, Print CG, Baguley BC, Eccles MR (2009) A gene expression signature of invasive potential in metastatic melanoma cells. PLoS One 4(12):e8461. doi:10.1371/journal.pone.0008461
18. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277-300. doi:10.3322/caac.20073
19. Jeter CR, Badeaux M, Choy G, Chandra D, Patrawala L, Liu C, Calhoun-Davis T, Zaehres H, Daley GQ, Tang DG (2009) Functional evidence that the self-renewal gene Nanog regulates human tumor development. Stem Cells 27(5):993-1005. doi: 10.1002/stem.29
20. Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ, Mongan NP (2009) Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the Nanog, Oct4, and Sox2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 18(7):1093-1108. doi:10.1089/scd.2009.0113
21. Kinch MS, Carles-Kinch K (2003) Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer. Clin Exp Metastasis 20(1):59-68 (Pubitemid 36308137)
22. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402-408. doi:10.1006/meth. 2001.1262 (Pubitemid 34164012)
23. Martins I, Sylla K, Deshayes F, Lauriol J, Ghislin S, Dieu-Nosjean MC, Viguier M, Verola O, Charron D, Alcaide-Loridan C, Al- Daccak R (2009) Coexpression of major histocompatibility complex class II with chemokines and nuclear NFkappaB p50 in melanoma: a rational for their association with poor prognosis. Melanoma Res 19(4):226-237. doi:10.1097/CMR.0b013 e32832e0bc3
24. Pankova K, Rosel D, Novotny M, Brabek J (2010) The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cell Mol Life Sci 67(1):63-71. doi: 10.1007/s00018-009-0132-1
25. Parri M, Taddei ML, Bianchini F, Calorini L, Chiarugi P (2009) EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res 69(5):2072-2081. doi:10.1158/0008-5472. CAN-08- 1845
26. Perego M, Tortoreto M, Tragni G, Mariani L, Deho P, Carbone A, Santinami M, Patuzzo R, Mina PD, Villa A, Pratesi G, Cossa G, Perego P, Daidone MG, Alison MR, Parmiani G, Rivoltini L, Castelli C (2010) Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells. J Invest Dermatol 130(7):1877-1886. doi:10.1038/jid.2010.69
27. Pinner S, Sahai E (2008) PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat Cell Biol 10(2):127-137. doi:10.1038/ncb1675 (Pubitemid 351194042)
28. Ramgolam K, Lauriol J, Lalou C, Lauden L, Michel L, de la Grange P, Khatib AM, Aoudjit F, Charron D, Alcaide-Loridan C, Al- Daccak R (2011) Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function. PLoS One 6(4):e18784. doi:10.1371/journal.pone.0018784
29. Sahai E, Garcia-Medina R, Pouyssegur J, Vial E (2007) Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J Cell Biol 176(1):35-42. doi:10.1083/jcb.200605135 (Pubitemid 46041678)
30. Sakamoto S, McCann RO, Dhir R, Kyprianou N (2010) Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res 70(5):1885-1895. doi:10.1158/0008-5472.CAN-09-2833
31. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ (2008) Rac activation and inactivation control plasticity of tumor cell movement. Cell 135(3):510-523. doi:10.1016/j.cell.2008.09.043
32. Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY, Cheung AN (2008) Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol 173(4):1165-1172. doi:10.2353/ajpath.2008.080288
33. Tan TK, Zheng G, Hsu TT, Wang Y, Lee VW, Tian X, Cao Q, Harris DC (2010) Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 176(3):1256-1270. doi:10.2353/ ajpath.2010.090188
34. Tumbarello DA, Brown MC, Hetey SE, Turner CE (2005) Regulation of paxillin family members during epithelial-mesenchymal transformation: a putative role for paxillin delta. J Cell Sci 118(Pt 20):4849-4863. doi:10.1242/jcs.02615 (Pubitemid 41646392)
35. Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH, Wrana JL (2003) Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302(5651):1775-1779. doi:10.1126/science.1090772 (Pubitemid 37505743)
36. Wen J, Park JY, Park KH, Chung HW, Bang S, Park SW, Song SY (2010) Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis. Pancreas 39(5):622-626. doi:10.1097/MPA.0b013e3181c75f5e
37. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P (2003) Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160(2):267-277. doi:10.1083/jcb.200209006 (Pubitemid 36254960)
38. Yilmaz M, Christofori G (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8(5):629-642. doi:10.1158/1541-7786. MCR-10-0139